Point72 Hong Kong LTD Gritstone Bio, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.77 - $4.34 $18,158 - $44,524	-10,259 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.03 - $12.19 $41,343 - $125,057	10,259 New	10,259 $42,000
Q3 2020 Nov 16, 2020	SELL	$2.63 - $8.09 $1,822 - $5,606	-693 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$5.69 - $8.17 $3,943 - $5,661	693 New	693 $5,000
Q4 2018 Feb 14, 2019	SELL	$11.61 - $31.1 $79,156 - $212,039	-6,818 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.24 - $14.24 $97,088 - $97,088	6,818 New	6,818 $97,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.